About Oncologica
Oncologica is a Healthcare company based in Saffron Walden (United Kingdom) founded in 2003 by Marco Loddo and Gareth Haydn Williams. DNA-based cancer tests for precision oncology are developed. Oncologica has raised $976.12 thousand across 1 funding round. The company has 272 employees. Oncologica offers products and services including Oncofocus, ProstateFocus, and Genomic Research Services. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Kits and Reagents. Its legal entity is ONCOLOGICA UK LIMITED.
Company details
Oncologica was founded in 2003 in Saffron Walden, United Kingdom, within the biotechnology sector focused on oncology. Genomic profiling tests for precision medicine are provided by the company, alongside the Immunofocus IHC assay, which delivers tumor scores to predict therapy responses. Operations center on DNA analysis to support targeted cancer treatments, with activities based in the UK.
- Headquarters Saffron Walden, United Kingdom
- Employees 272
- Founders Marco Loddo, Gareth Haydn Williams
- SectorsHealthcare
- Website oncologica.com
- Social LinkedIn
- Legal Name Oncologica Uk Limited
- Date of Incorporation 11 Nov, 2014
- Jurisdiction CAMBRIDGE, ENGLAND
- Total Equity Funding$976.12K (USD)
in 1 rounds
- Latest Funding Round$976.12K (USD), Seed
Oct 2020
- Employee Count272
Products & Services of Oncologica
Oncologica offers a comprehensive portfolio of products and services, including Oncofocus, ProstateFocus, and Genomic Research Services.
Matches tumor genetics with targeted therapies for personalized cancer treatment.
Non-invasive urine test for early prostate cancer detection.
Provides high-quality genetic testing and bioinformatics solutions.
Funding Insights of Oncologica
Oncologica has successfully raised a total of $976.12K through 1 strategic funding round. The most recent funding activity was a Seed round of $976.12 thousand completed in October 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $976,121
- Total Rounds 1
- Last Round Seed — $976,121
- First Round $976,121
(Oct 2020)
All 1 funding rounds of Oncologica with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2020 | $976,121 | Seed | – | – | – |
People of Oncologica
2 people are tracked at Oncologica (2 in leadership); the tracked headcount is 272.
| Name | Role | Group |
|---|---|---|
Marco Loddo | Co-Founder | Leadership |
Gareth Haydn Williams | Co-Founder | Leadership |
Complete people profiles for Oncologica
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Oncologica
2 dated milestones of Oncologica across 17 years, from founding to its latest funding, stage changes and deals.
- Founded Oncologica is founded.
- Funding First funding round of $976K.
Top companies in Genomics & Gene Therapy Platforms
2 companies that operate in the same segment as Oncologica (Genomics & Gene Therapy Platforms) in United Kingdom, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Oncologica
Complete news archive for Oncologica
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Oncologica
Oncologica was founded in 2003 and raised its 1st funding round 17 years after it was founded.
Oncologica is headquartered in Saffron Walden, United Kingdom. It is registered at Saffron Walden, Essex, United Kingdom.
Oncologica is a funded company, having raised a total of $976.12K across 1 funding round to date. The company's 1st funding round was a Seed of $976.12K, raised on Oct 2020.
Oncologica has 272 employees.
Oncologica was founded in 2003 in Saffron Walden, United Kingdom, within the biotechnology sector focused on oncology. Genomic profiling tests for precision medicine are provided by the company, alongside the Immunofocus IHC assay, which delivers tumor scores to predict therapy responses. Operations center on DNA analysis to support targeted cancer treatments, with activities based in the UK.
Oncologica offers Oncofocus, ProstateFocus, and Genomic Research Services.
Oncologica operates through Oncologica Uk Limited.